क्यूआर कोड

CD20 × CD3 Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas: Current Evidence, Therapeutic Integration, and Future Directions

<i>Background and Objectives</i>: Relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHL) remain associated with poor outcomes despite advances in chemoimmunotherapy and chimeric antigen receptor (CAR) T-cell therapy. Many patients are ineligible for or relapse after cellular therapies, hi...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Polyxeni Giamaiou, Rodanthi Fioretzaki, Theodoros P. Vassilakopoulos, Maria Dimou
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2026-05-01
श्रृंखला:Medicina
विषय:
bispecific antibodies
CD20 × CD3
B-cell non-Hodgkin lymphoma
diffuse large B-cell lymphoma
follicular lymphoma
CRS
ऑनलाइन पहुंच:https://www.mdpi.com/1648-9144/62/6/1056
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन